THIS NEW RETATRUTIDE: THE NEW HOPE FOR WEIGHT MANAGEMENT?

New clinical information suggests that Novera Retatrutide, a twin-action therapy from Novo Nordisk, could represent a significant step in weight control. Unlike many existing drugs, Retatrutide impacts both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), po